Table 2 The relationship between MRI findings and the treatment success
Parameters | Treatment success | ||||
|---|---|---|---|---|---|
Recurrence (%) | Yes (%) | No (%) | Total | p | |
Quadrants | |||||
Other quadrants | 0 (%0.0) | 40 (%90.9) | 15 (%88.2) | 55 | 0.018* |
Retroareolar | 1 (%100) | 4 (%9.1) | 2 (%11.8) | 7 | |
MRG lesion | |||||
Mass | 0 (%0.0) | 2 (%4.5) | 1 (%5.9) | 3 | 0.976 |
Mass + NME | 1 (%100) | 31 (%70.5) | 12 (%70.6) | 44 | |
NME | 0 (%0) | 11 (%25.0) | 4 (%23.5) | 15 | |
MRI mass | |||||
Abcess | 1 (%100) | 27 (%81.8) | 11 (%84.6) | 39 | 0.878 |
Solid | 0 (%0) | 6 (%18.2) | 2 (%15.4) | 8 | |
Shape | |||||
Irregular | 0 (%0) | 12 (%36.4) | 4 (%30.8) | 16 | 0.544 |
Oval | 0 (%0) | 1 (%3) | 2 (%15.4) | 3 | |
Round | 1 (%100) | 20 (%60.6) | 7 (%53.8) | 28 | |
Margin | |||||
Irregular | 0 (%0) | 9 (%27.3) | 3 (%23.1) | 12 | 0.914 |
Well-circumsribed | 1 (%100) | 23 (%69.7) | 9 (%69.2) | 33 | |
Spiculated | 0 (%0) | 1 (%3) | 1 (%7.7) | 2 | |
Mass enhancement | |||||
Heterogeneous | 0 (%0) | 4 (%12.1) | 1 (%7.7) | 5 | 0.570 |
Homogeneous | 0 (%0) | 0 (%0) | 1 (%7.7) | 1 | |
Rim enhancement | 1 (%100) | 29 (%87.9) | 11 (%84.6) | 41 | |
Nonmass enhancement | |||||
Regional | 0 (%0) | 22 (%53.7) | 11 (%68.8) | 33 | 0.271 |
Diffusse | 0 (%0) | 2 (%4.9) | 1 (%6.3) | 3 | |
Focal | 1 (%100) | 5 (%12.2) | 0 (%0) | 6 | |
Lineer | 0 (%0) | 2 (%4.9) | 0 (%0) | 2 | |
Multiple regional | 0 (%0) | 9 (%22) | 4 (%25) | 13 | |
Segmental | 0 (%0) | 1 (%) | 0 (%0) | 1 | |
NME (internal) | |||||
Heterogeneous | 0 (%0) | 25 (%59.5) | 6 (%37.5) | 31 | 0.298 |
Homogeneous | 0 (%0) | 8 (%19) | 6 (%37.5) | 14 | |
Clumped | 0 (%0) | 2 (%4.8) | 1 (%6.3) | 3 | |
Clustered | 1 (%100) | 7 (%16.7) | 3 (%18.8) | 11 | |